$2.18 Billion is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 116 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 156.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | Buy | SPDR S&P 500 ETF TRput | $381,402,000 | +203.5% | 1,763,300 | +193.9% | 17.49% | +153.0% |
HZNP | Buy | HORIZON PHARMA PLC | $123,590,000 | +85.0% | 6,816,903 | +68.1% | 5.67% | +54.3% |
AMZN | New | AMAZON COM INC | $78,839,000 | – | 94,157 | +100.0% | 3.62% | – |
HZNP | Buy | HORIZON PHARMA PLCcall | $66,187,000 | +105.3% | 3,650,700 | +86.5% | 3.03% | +71.1% |
APA | New | APACHE CORP | $48,625,000 | – | 761,308 | +100.0% | 2.23% | – |
NXST | Buy | NEXSTAR BROADCASTING GROUP Icl a | $47,032,000 | +44.6% | 814,973 | +19.2% | 2.16% | +20.6% |
IP | New | INTL PAPER CO | $46,724,000 | – | 973,831 | +100.0% | 2.14% | – |
HRTX | Buy | HERON THERAPEUTICS INC | $46,452,000 | +182.5% | 2,695,997 | +195.9% | 2.13% | +135.6% |
Buy | HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $40,850,000 | +39.8% | 42,250,000 | +31.0% | 1.87% | +16.6% | |
HLF | Buy | HERBALIFE LTD | $39,515,000 | +350.1% | 637,449 | +325.0% | 1.81% | +275.2% |
KBE | New | SPDR SERIES TRUSTcall | $33,453,000 | – | 1,002,200 | +100.0% | 1.53% | – |
C | Buy | CITIGROUP INC | $32,812,000 | +2502.1% | 694,733 | +2236.0% | 1.50% | +2079.7% |
WPX | Buy | WPX ENERGY INC | $31,125,000 | +48.0% | 2,359,722 | +4.5% | 1.43% | +23.4% |
PF | Buy | PINNACLE FOODS INC DEL | $30,766,000 | +232.3% | 613,226 | +206.6% | 1.41% | +177.2% |
FTV | New | FORTIVE CORP | $26,027,000 | – | 511,333 | +100.0% | 1.19% | – |
CB | Buy | CHUBB LIMITED | $24,339,000 | +0.4% | 193,705 | +4.5% | 1.12% | -16.2% |
SAGE | Buy | SAGE THERAPEUTICS INC | $23,347,000 | +307.6% | 506,990 | +166.7% | 1.07% | +239.7% |
DVMT | New | DELL TECHNOLOGIES INC | $22,640,000 | – | 473,643 | +100.0% | 1.04% | – |
LEN | New | LENNAR CORPcl a | $21,997,000 | – | 519,532 | +100.0% | 1.01% | – |
CPE | New | CALLON PETE CO DEL | $20,099,000 | – | 1,280,198 | +100.0% | 0.92% | – |
GIS | New | GENERAL MLS INCcall | $19,164,000 | – | 300,000 | +100.0% | 0.88% | – |
LITE | Buy | LUMENTUM HLDGS INC | $15,415,000 | +183.1% | 369,052 | +64.0% | 0.71% | +136.5% |
EXP | New | EAGLE MATERIALS INC | $14,942,000 | – | 193,305 | +100.0% | 0.68% | – |
AAL | Buy | AMERICAN AIRLS GROUP INC | $14,641,000 | +4231.7% | 838,238 | +86.3% | 0.67% | +3431.6% |
LXRX | Buy | LEXICON PHARMACEUTICALS INC | $14,631,000 | +106.2% | 809,666 | +63.8% | 0.67% | +72.1% |
TPX | New | TEMPUR SEALY INTL INC | $14,452,000 | – | 254,700 | +100.0% | 0.66% | – |
ESRX | Buy | EXPRESS SCRIPTS HLDG COput | $14,134,000 | +86.5% | 200,400 | +100.4% | 0.65% | +55.4% |
EXEL | New | EXELIXIS INCcall | $14,078,000 | – | 1,100,700 | +100.0% | 0.64% | – |
SHW | New | SHERWIN WILLIAMS CO | $13,800,000 | – | 49,880 | +100.0% | 0.63% | – |
GWPH | New | GW PHARMACEUTICALS PLCput | $13,286,000 | – | 100,100 | +100.0% | 0.61% | – |
DVAX | Buy | DYNAVAX TECHNOLOGIES CORPcall | $12,644,000 | +8.4% | 1,205,300 | +50.7% | 0.58% | -9.5% |
FLS | New | FLOWSERVE CORP | $12,026,000 | – | 249,300 | +100.0% | 0.55% | – |
LMT | New | LOCKHEED MARTIN CORP | $11,522,000 | – | 48,066 | +100.0% | 0.53% | – |
ENH | Buy | ENDURANCE SPECIALTY HLDGS LT | $10,583,000 | +52.8% | 161,700 | +56.8% | 0.48% | +27.3% |
CSX | New | CSX CORP | $10,166,000 | – | 333,320 | +100.0% | 0.47% | – |
TAPA | New | MOLSON COORS BREWING COcl a | $9,824,000 | – | 89,473 | +100.0% | 0.45% | – |
BXMT | New | BLACKSTONE MTG TR INC | $9,542,000 | – | 324,000 | +100.0% | 0.44% | – |
SGYPQ | Buy | SYNERGY PHARMACEUTICALS DEL | $9,028,000 | +48.2% | 1,638,410 | +2.2% | 0.41% | +23.6% |
OTIC | Buy | OTONOMY INC | $9,005,000 | +54.3% | 495,074 | +34.7% | 0.41% | +28.7% |
FATE | Buy | FATE THERAPEUTICS INC | $8,823,000 | +129.9% | 2,827,889 | +25.2% | 0.40% | +91.9% |
Buy | LIBERTY MEDIA CORPdeb 4.000%11/1 | $8,645,000 | +24.7% | 14,000,000 | +16.7% | 0.40% | +3.9% | |
RTRX | New | RETROPHIN INC | $8,506,000 | – | 380,075 | +100.0% | 0.39% | – |
LLY | Buy | LILLY ELI & COcall | $8,090,000 | +2.7% | 100,800 | +0.8% | 0.37% | -14.3% |
PG | New | PROCTER AND GAMBLE CO | $8,076,000 | – | 89,985 | +100.0% | 0.37% | – |
K | New | KELLOGG COcall | $7,747,000 | – | 100,000 | +100.0% | 0.36% | – |
New | INOTEK PHARMACEUTICALS CORPnote 5.750% 8/0 | $7,670,000 | – | 5,700,000 | +100.0% | 0.35% | – | |
VNDA | Buy | VANDA PHARMACEUTICALS INCcall | $7,525,000 | +124.2% | 452,200 | +50.7% | 0.34% | +86.5% |
VRX | New | VALEANT PHARMACEUTICALS INTLcall | $7,382,000 | – | 300,700 | +100.0% | 0.34% | – |
CCEP | New | COCA COLA EUROPEAN PARTNERS | $7,134,000 | – | 178,808 | +100.0% | 0.33% | – |
TSRO | New | TESARO INC | $6,877,000 | – | 68,608 | +100.0% | 0.32% | – |
AMAG | New | AMAG PHARMACEUTICALS INC | $6,680,000 | – | 272,526 | +100.0% | 0.31% | – |
PEP | New | PEPSICO INC | $6,517,000 | – | 59,920 | +100.0% | 0.30% | – |
IVTY | Buy | INVUITY INC | $6,368,000 | +205.0% | 464,150 | +111.8% | 0.29% | +153.9% |
CLCD | New | COLUCID PHARMACEUTICALS INC | $5,912,000 | – | 154,963 | +100.0% | 0.27% | – |
VSAR | Buy | VERSARTIS INC | $5,893,000 | +68.5% | 481,056 | +52.1% | 0.27% | +40.6% |
HOPE | New | HOPE BANCORP INC | $5,495,000 | – | 316,339 | +100.0% | 0.25% | – |
KLXI | New | KLX INC | $5,323,000 | – | 151,208 | +100.0% | 0.24% | – |
STZ | New | CONSTELLATION BRANDS INCcl a | $5,126,000 | – | 30,790 | +100.0% | 0.24% | – |
ENTL | Buy | ENTELLUS MED INC | $5,071,000 | +23.2% | 228,647 | +1.5% | 0.23% | +2.7% |
TSRO | Buy | TESARO INCcall | $5,022,000 | +139.0% | 50,100 | +100.4% | 0.23% | +98.3% |
GILD | New | GILEAD SCIENCES INC | $4,642,000 | – | 58,668 | +100.0% | 0.21% | – |
VIRT | New | VIRTU FINL INCcl a | $4,317,000 | – | 288,408 | +100.0% | 0.20% | – |
NOVN | New | NOVAN INC | $3,994,000 | – | 197,940 | +100.0% | 0.18% | – |
ZLTQ | New | ZELTIQ AESTHETICS INCput | $3,922,000 | – | 100,000 | +100.0% | 0.18% | – |
AERI | New | AERIE PHARMACEUTICALS INCput | $3,774,000 | – | 100,000 | +100.0% | 0.17% | – |
EBS | New | EMERGENT BIOSOLUTIONS INCcall | $3,260,000 | – | 103,400 | +100.0% | 0.15% | – |
SRPT | New | SAREPTA THERAPEUTICS INCput | $3,071,000 | – | 50,000 | +100.0% | 0.14% | – |
HCA | Buy | HCA HOLDINGS INC | $3,063,000 | +54.5% | 40,496 | +57.3% | 0.14% | +28.4% |
KR | New | KROGER CO | $2,944,000 | – | 99,200 | +100.0% | 0.14% | – |
ATRS | Buy | ANTARES PHARMA INC | $2,733,000 | +103.5% | 1,626,738 | +27.2% | 0.12% | +68.9% |
DEPO | New | DEPOMED INCput | $2,497,000 | – | 100,000 | +100.0% | 0.11% | – |
INFY | New | INFOSYS LTDput | $2,179,000 | – | 138,100 | +100.0% | 0.10% | – |
AXGT | New | AXOVANT SCIENCES LTD | $1,739,000 | – | 124,188 | +100.0% | 0.08% | – |
AZN | Buy | ASTRAZENECA PLCcall | $1,699,000 | +9.7% | 51,700 | +0.8% | 0.08% | -8.2% |
KNSL | New | KINSALE CAP GROUP INC | $1,650,000 | – | 75,000 | +100.0% | 0.08% | – |
OPHT | New | OPHTHOTECH CORPcall | $1,527,000 | – | 33,100 | +100.0% | 0.07% | – |
ARIA | New | ARIAD PHARMACEUTICALS INCput | $1,369,000 | – | 100,000 | +100.0% | 0.06% | – |
JAGX | Buy | JAGUAR ANIMAL HEALTH INC | $1,291,000 | -22.8% | 1,008,642 | +10.9% | 0.06% | -35.9% |
HIG | New | HARTFORD FINL SVCS GROUP INC | $1,261,000 | – | 29,444 | +100.0% | 0.06% | – |
REPH | New | RECRO PHARMA INC | $1,017,000 | – | 115,000 | +100.0% | 0.05% | – |
ADHD | New | ALCOBRA LTD | $980,000 | – | 396,800 | +100.0% | 0.04% | – |
KDMN | New | KADMON HLDGS INC | $379,000 | – | 54,333 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
ISHARES TR | 27 | Q3 2023 | 13.2% |
HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
AMAZON COM INC | 18 | Q3 2022 | 7.6% |
SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-04-15 |
13F-HR/A | 2024-03-18 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-06 |
SC 13G/A | 2024-02-06 |
SC 13G/A | 2023-11-29 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G | 2023-04-13 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.